Loading clinical trials...
Loading clinical trials...
The Exploratory Study on Clinical Rational Use of Rivaroxaban Dosing in Elderly Chinese Population
Conditions
Interventions
Direct oral anticoagulant
Locations
1
China
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
Start Date
April 1, 2021
Primary Completion Date
September 30, 2026
Completion Date
September 30, 2026
Last Updated
January 8, 2024
NCT06183944
NCT06189313
NCT07015905
NCT03728166
NCT07310693
NCT07288632
Lead Sponsor
Peking Union Medical College Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions